The lateral preoptic area (LPO) and ventral pallidum (VP) are structurally and functionally distinct territories in the subcommissural basal forebrain. It was recently shown that unilateral infusion of the GABA A receptor antagonist, bicuculline, into the LPO strongly invigorates exploratory locomotion, whereas bicuculline infused unilaterally into the VP has a negligible locomotor effect, but when infused bilaterally, produces vigorous, abnormal pivoting and gnawing movements and compulsive ingestion. This study was done to further characterize these responses. We observed that bilateral LPO infusions of bicuculline activate exploratory locomotion only slightly more potently than unilateral infusions and that unilateral and bilateral LPO injections of the GABA A receptor agonist muscimol potently suppress basal locomotion, but only modestly inhibit locomotion invigorated by amphetamine. In contrast, unilateral infusions of muscimol into the VP affect basal and amphetamine-elicited locomotion negligibly, but bilateral VP muscimol infusions profoundly suppress both. Locomotor activation elicited from the LPO by bicuculline was inhibited modestly and profoundly by blockade of dopamine D2 and D1 receptors, respectively, but was not entirely abolished even under combined blockade of dopamine D1 and D2 receptors. That is, infusing the LPO with bic caused instances of near normal, even if sporadic, invigoration of locomotion in the presence of saturating dopamine receptor blockade, indicating that LPO can stimulate locomotion in the absence of dopamine signaling. Pivoting following bilateral VP bicuculline infusions was unaffected by dopamine D2 receptor blockade, but was completely suppressed by D1 receptor blockade. The present results are discussed in a context of neuroanatomical and functional organization underlying exploratory locomotion and adaptive movements.
Introduction
It has been reported for more than 30 years that activating the subcommissural basal forebrain of rats by micro-infusing a GABA A receptor antagonist, such as picrotoxin or bicuculline (bic), greatly augments locomotion and rearing (Mogenson et al. , 1985 (Mogenson et al. , 1993 Uretsky 1989, 1991; Mogenson and Yang 1991; Kalivas et al. 1991; Wallace and Uretsky 1991; Johnson et al. 1996; Willens et al. 1992; Gong et al. 1999; Johnson and Napier 2000; Chen et al. 2001; June et al. 2003; Reynolds et al. 2006; Hubert et al. 2010) , whereas similarly localized infusions of a GABA A agonist, such as muscimol (musc), suppresses these (Mogenson et al. 1980; Mogenson and Nielsen 1983; Shreve and Uretsky 1988; Austin and Kalivas 1989 and other (e.g., Hooks et al. 1995; Ma et al. 1996; Numan et al. 2005) behaviors. The subcommissural basal forebrain, in conjunction with parts of the lateral hypothalamus and zona incerta (Sinnamon 1992 (Sinnamon , 1993 Mitrofanis 2005; Yetnikoff et al. 2015) , is thought to comprise the final telencephalic link in circuitry conveying information from the prefrontal cortex, hippocampus and amygdala to the motivational circuitry and brainstem motor effectors (Heimer et al. 1985 (Heimer et al. , 1995 . Like all parts of brain, the subcommissural region is anatomically and functionally complex (Alheid and Heimer 1988; Heimer et al. 1991 Heimer et al. , 1997 Heimer and Alheid 1991; Heimer and Van Hoesen 2006) and it has been reported recently (Zahm et al. 2014 ) that the remarkably invigorated but otherwise structurally normal locomotion and rearing elicited by infusing bic into one of its subdivisions, the lateral preoptic area (LPO), look nothing like the postural twisting, vigorous pivoting movements, gnawing and compulsive ingesting that result from infusing bic into the ventral pallidum (VP), another, adjacent, subcommissural structure (Heimer 1972; Heimer and Van Hoesen 1978; Heimer et al. 1982; Zahm and Brog 1992; Root et al. 2015) .
Stimulating the LPO in the rat invigorates natural appearing, smoothly coordinated actions dominated by forward locomotion and punctuated by much rearing, pausing, observing, and frequent changes in direction, which, aside from the stepped up tempo, resemble spontaneous, 'exploratory' behavior (reviewed in Sinnamon 1993, and; Jordan 1998) , also referred to as 'seeking' behavior (reviewed in Panksepp 1998; Ikemoto and Panksepp 1999; Alcaro et al. 2007) . The response to VP stimulation, in contrast, consists of clearly unnatural exaggerations or distortions of adaptive movements. Nonetheless, it is likely that signals conducted by descending axonal projections engage both structures in the service of telencephalic control of adaptive behavior (Alheid and Heimer 1988; Swanson 2000; Heimer and Van Hoesen 2006; Zahm 2006) . The experiments described here were done to further refine our understanding of functional-anatomical substrates underlying both kinds of response.
Methods

Animals
Male Sprague-Dawley rats (Harlan, Indianapolis, IN) weighing 250-375 g were used in accordance with policy mandated in the Public Health Service Policy on Humane Care and Use of Laboratory Animals (http://grant s.nih.gov/ grant s/olaw/refer ences /phspo l.htm) provided by the U.S. Department of Health and Human Services. The rats were housed in standard conditions on a 12-h light-dark cycle with ad libitum access to food and water in groups of two to four prior to surgeries and singly thereafter.
Placement of guide cannulae
Rats were deeply anesthetized by intraperitoneal injections of a mixture of ketamine (72 mg/kg) and xylazine (11.2 mg/kg) given as a cocktail consisting of 45% ketamine (100 mg/ml), 35% xylazine (20 mg/ml) and 20% saline at 0.16 ml/100 g of body weight and fixed in a Kopf stereotaxic instrument. Incisions were made to expose the skulls in which small burr holes were drilled over intended infusion sites. Guide cannulae, consisting of 13 mm lengths of 22 gauge stainless steel tubing (PlasticsOne, Roanoke, VA) were implanted in the openings unilaterally and bilaterally. Guides aimed at the preoptic area were set at an angle of 20° in the mediolateral plane so as to avoid the lateral ventricle; those aimed at the ventral pallidum were vertical. All were implanted to a depth 2 mm short of the centers of the intended targets and secured with dental cement anchored to stainless steel screws set in the skull. Stainless steel wire obturators were inserted into the guide cannulae to maintain patency. The incisions were closed with wound clips and the rats were kept warm until they awakened. A solution containing lidocaine was infused into the incisions and the rats were given i.p. injections of Buprenorphine SR (1 mg/ kg) before they awakened.
Behavioral testing
One week after cannula implantations and at least 20 min prior to testing, the rats were brought to a room containing 6 standard activity monitoring chambers, each comprising a square, white floor space (43 × 43 cm) enclosed by clear plexiglass walls 30.5 cm in height (Med Associates, St. Albans, VT). Horizontal rows of 16 point-source infrared illuminators equispaced at 2.54 cm were mounted on the wall on one side of the chambers at heights of 2.54 and 12.7 cm from the floor facing photodetectors mounted on the opposite walls. The lower illuminator-detector bank comprised two sets mounted at a right angle to each other so as to form a grid of 16 × 16 intersecting beams for measurement of horizontal (forward) locomotion, whereas the upper bank consisted of a single set to detect vertical locomotion (rearing). The detectors were connected to a PC and beam breaks were recorded with the aid of Activity Monitor software (Med Associates). The monitors were housed inside dimly illuminated sound attenuating chambers equipped with exhaust fans (Med Associates).
After removing the rats from the home cages and the obturators from the guide cannulae, infusions were done with the aid of 28-gauge stainless steel injector cannulae (Plastics One) cut to lengths of 15 mm so that when fully 1 3 inserted they protruded 2 mm beyond the ends of the guides. The injectors were connected by a short length of polyethylene tubing (PE 20 0.38/1.09, Stoelting, Wood Dale, IL, cat. # 51, 155) to the Luer needle of a 1.0 µl Hamilton syringe mounted in a syringe pump (Harvard Apparatus, Holliston, MA, model '11' plus) calibrated to eject solution at a rate of 0.25 μl/min.
Drugs
All chemicals and drugs, except as noted, were acquired from the Sigma Chemical Company (St. Louis, MO, USA). The drugs were dissolved in sterile 0.9% sodium chloride (Hospira Inc., Lake Forest, IL), except haloperidol (hal), S(-)-eticlopride hydrochloride (etic) and R(+)-SCH-23390 hydrochloride (SCH), which were dissolved in a vehicle of 20% ethanol, 50% propylene glycol and 30% dH 2 O.
Infused drugs the gamma-aminobutyric acid A (GABA A ) receptor antagonist, 9(R)-(-)-bicuculline methbromide (bic), was prepared at a dilution of 1 mg/3 ml vehicle, which resulted in delivery of 67 ng in 0.25 µl/60 s of infusion. This concentration and rate of delivery produced robust locomotor activation in previous studies (Reynolds et al. 2006; Zahm et al. 2014) . The GABA A receptor agonist, muscimol hydrobromide (musc, Sigma and Tocris Bioscience, Avonmouth, Bristol, UK), was prepared at a dilution of 1 mg/2 ml vehicle, which resulted in delivery of 75 ng in 0.25 µl/60 s of infusion.
Injected drugs D-Amphetamine hemisulfate salt C-II (amph) was prepared at a dilution of 1.5 mg/ml vehicle and injected at a dose of 1.5 mg/kg. Hal and etic were prepared at a dilution of 2 mg/ml and SCH at 5 mg/ml and these were given at 2 and 5 mg/kg, respectively (see, Discussion, Methodological considerations, below). Hal and etic preferentially bind D2-D3 class relative to D1 dopamine receptors, whereas SCH preferentially binds D1 (Christensen et al. 1984; Hall et al. 1985; Köhler et al. 1986; Leslie et al. 1987a, b; Sokoloff et al. 1990; Bourne 2001) . A cocktail of hal and SCH was used in order to block D1 and D2 receptors (Zahm 1992) .
Localization of infusion sites
The rats were deeply anesthetized precisely as described above and subjected to transaortic perfusion with 0.01 M Sorenson's phosphate buffer (SPB; pH 7.4) containing 0.9% sodium chloride and 2.5% sucrose, followed by 0.1 M SPB (pH 7.4) containing 4% paraformaldehyde and 2.5% sucrose. The perfused brains were removed and placed in the same fixative for at least 4 h and then overnight at 4 °C with agitation in 0.01 M SPB (pH 7.4) containing 30% sucrose. The brains were cut on a cryostat into five adjacent series of 50 μm thick sections of which the first series of sections was thaw mounted on subbed glass slides and the rest were collected and stored in separate glass vials at − 20 °C in cryoprotectant consisting of 0.01 M SPB containing 30% sucrose and 30% ethylene glycol. The mounted sections were defatted in Coplin jars in 1:1 alcohol/chloroform for at least 4 h, immersed in 0.1% cresyl violet solution for 5-10 min, rinsed quickly in distilled water, differentiated in 95% ethyl alcohol for 2-30 min, dehydrated in 100% ethanol 2 × 5 min, cleared in xylene 2 × 5 min and coverslipped with Permount. The ends of the infusion cannula tracks, which we regard as the injection sites, were identified by light microscopy with the 2x objective and mapped by reference to an atlas (Paxinos and Watson 2007) and immunohistochemical preparations archived in our laboratory.
Experimental groups and statistics
During the course of the study guide cannulae were implanted, mainly bilaterally, into the LPO and VP of, respectively, 83 and 56 rats. After a week of recovery, measurements were done on each rat with different combinations of injection (saline, amph, dopamine antagonists) and infusion (vehicle, bic or musc infused unilaterally or bilaterally) on five consecutive days under vigilance for lethargy or other signs of illness, detection of which warranted immediate removal of a rat from the study. Duplicate measurements (same drug-infusion combination more than once in the same rat) were mostly avoided. Sample sizes are given in the graphs (Figs. 1, 4 , 5, 6) above the bars.
Two test protocols were used. In the first, rats were placed into monitors one minute following infusions into the LPO or VP of bic or musc and locomotion and rearing were monitored for 20 min. Alternatively, following injections of amph, hal, etic, SCH or a cocktail of SCH and hal, the rats were returned to the home cage for 10 min and then placed in the monitor for 10 min, during which locomotion and rearing were monitored under the developing influence of the injected drugs and after which they were removed from the monitors in order for bic, musc or vehicle to be infused into the LPO or VP. Upon completion of unilateral or successive infusions on both sides of the midline, the rats were returned to the monitor for continuing measurement of locomotion and rearing until the monitoring session ended 40 min after it began. Figure 1A , B show representative time-course data acquired during 20 min immediately following infusion of vehicle, bic or musc into the LPO or VP bilaterally and unilaterally. For the 40 min protocol, similar data were collected during a comparable period of 20 min beginning 2 min after the rats were returned to the monitors after receiving infusions. This occurred 20-25 min after they had received drug or saline injections. Group means of the sums of data collected during these 20 min windows as shown in Fig. 1C-F Fig. 1 Graphs illustrating locomotion and rears, including representative time courses (A and B), during 20 min following unilateral and bilateral infusions of vehicle, bicuculline (bic) or muscimol (musc) into the lateral preoptic area (LPO, panels A-D) and unilateral and bilateral infusions of musc into the ventral pallidum (VP, panels E and F). Data describing bic infusions into the VP have been reported (Zahm et al. 2014 ) and so are omitted in E and F. Numbers above the bars in C and E are n values. Totals for the entire twenty minute period, as shown in C-F, were evaluated statistically using a one way ANOVA, results of which are given in the text. Asterisks shown beneath the panels reflect statistically significant differences revealed by the Student-Newman-Keuls post hoc test were tested using a one-way analysis of variance and the Student-Newman-Keuls post hoc test. Zahm et al. (2014) speculated that unilateral and bilateral infusions of bic into the LPO (Fig. 2) produce activations of locomotion and rearing of comparable magnitude, but did not test it. Accordingly, we here directly compared the effects on locomotor activation and rearing of unilateral and bilateral infusions of bic into the LPO.
Results
Infusions of bic and musc into the LPO
Significant main effects were associated with locomotion (F 4,90 = 80.786, p < 0.001) and rearing (F 4,90 = 19.323, p < 0.001). We observed that both unilateral and bilateral LPO infusions of bic strongly increase locomotion as compared to vehicle with bilateral bic infusions producing slightly greater activation (Fig. 1A, C) . Otherwise, nothing apparent distinguished the general structure of horizontal locomotion caused by unilateral and bilateral bic infusions. However, only unilateral LPO bic infusions, as compared to vehicle significantly increased rearing, which, after bilateral LPO bic infusions, approximated baseline levels (Fig. 1B, D) . Unilateral and bilateral LPO musc infusions suppressed locomotion (Fig. 1C) and rearing ( Fig. 1D ). Zahm et al. (2014) reported on unilateral and bilateral infusions of bic into the VP. Similar injection sites were used in the present study (Fig. 3 ), but we do not replicate data reported in the earlier study here (but see the control values in Fig. 4 ) except to note that the slight increase in average locomotion after unilateral VP bic infusions reported in the earlier study was not evident in this one and may have been due to diffusion of bic from VP into the LPO. Here, we observed significant main effects on locomotion (F 2,42 = 19.514, p < 0.001) and rearing (F 2,42 = 3.041, p < 0.001) after infusions of musc into the VP. Whereas baseline locomotion and rearing were not affected by unilateral VP musc infusions, both were suppressed by bilateral VP musc infusions (Fig. 1E, F) .
Infusions of musc into the VP
Effects of unilateral and bilateral LPO and VP musc infusions on locomotion and rearing stimulated by amph
Following unilateral and bilateral infusions of musc into the LPO and VP in rats that had received amph injections, significant main effects on locomotion (F 3,34 = 29.271, p < 0.001) and rearing (F 3,34 = 18.094, p < 0.001) were observed. The effects of unilateral and bilateral musc infusions into the LPO did not differ [Student t test -t = − 0.279 with 53 degrees of freedom. (P = 0.781)] and so the values were pooled. Infusions of musc into the LPO, as compared to vehicle, significantly reduced amph-stimulated locomotion ( Fig. 4A) and rearing (Fig. 4B) . Bilateral infusions into the VP of musc, as compared to vehicle, profoundly suppressed amph-stimulated locomotion (Fig. 4A) and rearing ( Fig. 4B ) to a degree greatly exceeding that produced by LPO musc (p < 0.001). In contrast, infusions of musc into the VP on only one side of the midline produced no decrease of amph-induced locomotion or rearing.
Effects of dopamine D2 and D1 antagonists on locomotion and rearing elicited by infusions of bic into the LPO and VP
Receptor-saturating doses of dopamine D2 and D1 antagonists were associated with significant main effects on locomotion (F 3,67 = 19.242, p < 0.001) and rearing (F 3,67 = 16.900, p < 0.001) elicited by infusions of bic into the LPO. The locomotor activating effect of unilateral and bilateral LPO bic infusion was significantly attenuated by pretreatment by hal and, significantly more so, SCH (Fig. 5A ). Co-administration of hal and SCH caused a suppression of the response to LPO bic infusion not different from that observed in rats given SCH alone. Rearing after LPO bic infusions was strongly suppressed by hal, SCH and combined administration of the two (Fig. 5B) .
The attenuation of LPO bic-elicited locomotion produced by SCH and the SCH/hal cocktail, while severe (Fig. 5A) , was not complete. That is to say, some LPO-infused rats pretreated with either SCH or the SCH/hal combination did indeed experience near complete suppression of LPO bic-induced locomotor activation (Fig. 5C, D) , but others exhibited sporadic bursts of modest and, occasionally, robust LPO bic-induced locomotion (see, e.g., Fig. 5D , cases 83 and 84). Thus, infusing the LPO with bic was able to cause instances of near normal, even if sporadic, invigoration of locomotion in the presence of saturating dopamine receptor blockade.
Receptor-saturating doses of dopamine D2 and D1 antagonists also were associated with significant main effects on locomotion (F 5,63 = 17.989, p < 0.001) and rearing (F 5,62 = 3.481, p < 0.008) elicited by infusions of bic into the VP. Modest locomotion (Fig. 6A ) and rearing ( Fig. 6B ) associated with bilateral infusions of bic into the VP were similar following administration of vehicle and the dopamine D2 antagonists hal and etic. Stated inversely, bilateral VP infusions of bic relieved (Fig. 6A ) the locomotor suppression (catalepsy) associated with administration of the D2 antagonists (Fig. 6A, light gray bar) . In contrast, catalepsy caused by SCH given alone or in combination with hal was not relieved by VP bic infusions.
The modest locomotor effects of bilateral VP bic infusions were accompanied by vigorous, obviously abnormal motor behaviors, as has been reported (Zahm et al. 2014) . Rats that had received bilateral VP bic infusions would, after a variable delay, lurch suddenly sidewards toward the tail or a hindlimb so forcefully as to whip the entire body in a near 360° pivot. Once such pivoting began, the rats frequently assumed a posture with head turned toward the tail or a hind paw, which sometimes were taken in the mouth, from which strenuous bouts of pivoting frequently occurred, commonly constituting five to seven rapidly sequential rotations and, not infrequently, up to twenty. However, despite the vigor of the movement, pivoting mostly was not recorded Fig. 4 Graphs showing effects on locomotion (A) and rearing (B) invigorated by subcutaneous administration of D-amphetamine (1.5 mg/kg) of infusion of muscimol (musc) into the lateral preoptic area (LPO) and ventral pallidum (VP). Rats were injected with amph, returned to the home cage for ten min and then were placed in activity monitors. After measurement of baseline activity for 10 min, they were removed, musc was infused and they were returned to the activity monitors for 20 min during which total locomotion and rearing were recorded (for a graph of the time course see Fig. 5E ). Numbers above the bars in A are n values. Totals for the 20 min period are shown and were evaluated statistically using a one way ANOVA, results of which are given in the text. Asterisks shown beneath the panels reflect statistically significant differences revealed by the Student-Newman-Keuls post hoc test by the activity monitor as locomotion because pivoting rats' centers of mass remained relatively stationary. Pivots were prominently unidirectional, but invariably accompanied by fewer or, rarely, equivalent numbers contralateral rotations. It was not unusual during the course of a pivoting episode for a rat to turn perhaps five to seven pivots toward one side before suddenly reversing direction to do multiple contraversive pivots. After an infusion, pivoting typically began after a delay of some minutes, peaked at about 10-15 min post-infusion and subsided thereafter, presumably in relation to the gradual dissociation of bic from GABA A receptors. Between pivoting episodes rats sometimes exhibited reverse (i.e., backward) stepping, but also moved around the activity monitor in a quite normal manner and, if provided edibles, compulsively ingested them [VP effects on ingestion have been extensively reported (e.g., Cromwell and Berridge 1993; Stratford et al. 1999; Shimura et al. 2006; Smith and Berridge 2007; Smith et al. 2009; Wirtshafter 2012, 2013; Covelo et al. 2014 ). We will address our data on ingestion in more detail in a separate communication (Reichard et al. in preparation) ].
Hal or etic given alone had no or little effect on abnormal movements elicited bilaterally from the VP, whereas SCH, given alone (Table 1 ) or in combination with hal completely suppressed pivoting. Notably, however, rats were not rendered paralyzed by SCH. Rather, between pivoting episodes, they (5 mg/kg) or co-administration of the two. Rats were injected with antagonist, returned to the home cage for 10 min and then were placed in activity monitors. After measurement of baseline activity for 10 min (C), they were removed, bic was infused and they were returned to the activity monitors for 20 min during which total locomotion and rearing were recorded (for a graph of the time course see panel C). For reference, broken horizontal lines in the white bars indicate baseline locomotion (A) and rearing (B), i.e., in the absence of bic infusions, transposed from Fig. 1 . Numbers above the bars in A are n values. Totals for the twenty minute period are shown and were evaluated statistically using a one way ANOVA, results of which are given in the text. Asterisks shown beneath panels A and B reflect statistically significant differences revealed by the StudentNewman-Keuls post hoc test. C Results for seven individual cases (12179-12184), indicating that SCH23390 frequently failed to suppress locomotion elicited by LPO bic infusions. D Total horizontal counts for more such cases. Case numbers are on the abscissa. Values of some of the bars are given above the bars repeatedly stretched their necks and upper bodies forward, backward and side to side, all the while whisking and seeming to take great interest in their surroundings; but the hindlimbs remained planted, which rendered the rats immobile, except when, on rare occasions, they would cross the floor of the activity monitor with apparently normal locomotion. They would also on occasion rear up against the chamber walls, particularly at the corners, supported by the forepaws, busily whisking side to side and up and down, and remain in this propped up position sometimes for many minutes. Like controls, SCH treated rats exerted vigorous escape efforts when handled by the investigator.
Fig. 6
Graphs showing effects on locomotion (A) and rearing (B) following infusions of bicuculline (bic) or vehicle (veh) into the ventral pallidum (VP) of subcutaneous administration of haloperidol (2 mg/ kg), SCH23390 (5 mg/kg) or co-administration of the two. Rats were injected with antagonist, returned to the home cage for 10 min and then were placed in activity monitors. After measurement of baseline activity for 10 min, they were removed, bic was infused and they were returned to the activity monitors for 20 min during which total locomotion and rearing were recorded (for a graph of the time course see panel 5C). The figure legend format is 'drug injected, compound infused into the VP'. For reference, broken horizontal lines in the white bars indicate baseline locomotion (A) and rearing (B), i.e., in the absence of bic infusions, transposed from Fig. 1 . Numbers above the bars in A are n values. Totals for the twenty minute period are shown and were evaluated statistically using a one way ANOVA, results of which are given in the text. Asterisks shown beneath panels A and B reflect statistically significant differences revealed by the Student-Newman-Keuls post hoc test. The hal, VP veh data are given to reference the severity of hal induced catalepsy in the absence of VP bic 
Discussion
Methodological considerations
Activation of the ionotropic GABA A receptor produces membrane hyperpolarization due to opening of chloride channels (Coombs et al. 1955; Eccles 1964; Kaila et al. 1989) . Ubiquitous among vertebrates and invertebrates, GABA A is expressed to some degree by virtually all neurons in the mammalian CNS (Nutt 2006) , such that each, to some degree, is inhibited by the GABA A agonist, musc, and disinhibited by its antagonists, bic and picrotoxin (Zukin et al. 1974; Dray 1975; Simmonds 1982; Krishek et al. 1996) . Accordingly, microinfusions of these drugs have been utilized in numerous experiments to make evident the influences on function of specific brain structures or regions. In practice, 'silencing' is frequently effective, whereas 'stimulation' tends more to occlude presumably functionally-specific patterns of neural activity, which creates difficulties in interpretation. Functional localization requires that infused GABA A ligands act only on structures to which effects are attributed. Because infusion sites are not visible histologically, this was done here with control infusions into several contiguous and nearby structures, including the bed nucleus of stria terminalis, ventral striatum, nucleus of the vertical limb of the diagonal band and olfactory tubercle. None produced behavior resembling that observed after LPO or VP bic and musc infusions. As regards the VP itself, however, only its central subcommissural part has been evaluated so far. Whether characteristic VP-elicited behavioral responses can be generated by infusions in other parts of the VP (Root et al. 2015) is not known. Behavioral activation has occasionally been reported after infusion of musc into the VP (Scheel-Krüger 1983; Swerdlow and Koob 1984; Baud et al. 1988; van den Bos and Cools 1989, 1991) , whereas we and others (references in Introduction) have consistently seen only behavioral suppression. We addressed this discrepancy separately by assessing bilateral infusions into the VP of musc at 75, 25 and 10 ng/0.25 µl/side, observing modest activation at the 10 ng dose (unpublished observation), possibly reflecting a presynaptic action of muscimol on GABAergic axon terminals (Yamamoto et al. 2011; Wakita et al. 2012) . Infusions of 25 and 75 ng consistently suppressed behavior in our hands.
With the hal-SCH combo used in this study, we sought to replicate complete dopamine depletion based on empirical data showing that an extraordinary effect on the distribution of striatal neurotensin immunoreactivity caused by reserpine (Bean et al. 1989 ) was reproduced only with a combo of hal and SCH at these doses (Zahm 1992) . Lesser doses of dopamine antagonist and dopamine-depleting 6-hydroxydopamine lesions failed to replicate the unique effect of reserpine, so the drug effect was attributed to the production of CNS extracellular concentrations of antagonist adequate to achieve full blockade of dopamine receptors. Importantly, lesser doses of dopamine antagonists also failed to block pivoting in the present study. A role for serotonin (5-HT) in mediating these effects cannot be excluded, however, insofar as reserpine also depletes serotonin stores and SCH at the high doses used blocks 5-HT1 and 5-HT5 receptors (Wamsley et al. 1991; Bourne 2001) . In this regard, the effect of the hal-SCH combo on striatal neurotensin immunoreactivity was not replicated by ritanserin, a potent 5-HT1 receptor antagonist, either when used alone or in combination with hal (Zahm 1992) .
LPO control of behavior
Our data indicate that locomotion is stimulated by LPO bic and that both basal and amph-stimulated locomotion are attenuated by LPO musc. LPO thus may trigger locomotion via signals conducted by its projections to upper brainstem somatomotor sites, such as, e.g., the subthalamic and midbrain locomotor regions, periaqueductal gray and retrorubral area Siegel 1975: 1978; Swanson et al. 1976; Saper et al. 1978; Zahm 2016) , which, in turn, project strongly to somatomotor regions in the caudal brainstem and spinal cord (Garcia-Rill et al. 1983; Garcia-Rill and Skinner 1987; Skinner et al. 1990; Skinner and Garcia-Rill 1993; Holstege 1991 Holstege , 1992 Holstege , 1996 Caggiano et al. 2018) . However, LPO also projects strongly to the VTA (Zahm et al. 2016) and activation (Mogenson et al. 1979; Lavezzi et al. 2014) and suppression (Reynolds et al. 2006; Liu et al. 2008 ) of VTA activity, respectively, increase and decrease extracellular dopamine in the Acb (Mogenson et al. 1979 (Mogenson et al. , 1980 Sotty et al. 2000) , which, respectively, stimulates and attenuates locomotion (Kelly et al. 1975) , much like LPO bic and musc infusions. In addition, the Acb has strong GABAergic and peptidergic projections to the LPO (Zahm et al. 2013 ) and other structures aligned along the medial forebrain bundle, including somatomotor sites to which LPO projects (Groenewegen and Russchen 1984; Heimer et al. 1991; Zahm and Heimer 1993; Usuda et al. 1998) .
Locomotor effects we would like to attribute to LPO stimulation might thus actually be exerted by the Acb. But, our data show that locomotion can be activated, even if in an attenuated, sporadic manner, by LPO bic administered during systemic blockade of dopamine D1 or D2 receptors and, importantly, combined blockade of both, i.e., full blockade of dopamine D1 and D2 receptor signaling. Furthermore, locomotion due to stimulation of the mesoaccumbens dopaminergic pathway is blocked by inhibition of the LPO and VP (Austin et and Kalivas 1989 Mogenson et al. 1980 ) and we also show that locomotor activation elicited by amph is attenuated by inactivation of the LPO, all of which suggests that increased Acb dopamine concentration activates locomotion via the LPO. Indeed the, robust locomotor activation caused by amph occurs despite dopamine autoreceptor-mediated suppression of the firing of VTA dopamine neurons caused by the increase in midbrain extracellular dopamine concentration due to the action of amph (Bunney et al. 1973; Einhorn et al. 1988; Shi et al. 2000a Shi et al. , b, 2004 . Independence of amph-evoked dopamine overflow from VTA neuronal firing has received further experimental support in the dorsal striatum (Westerink et al. 1987; Kuczenski et al. 1990 ), but to our knowledge, no similar determination was made in the Acb. In fact, amph-elicited locomotor activation is attenuated by low dose dopamine agonists, but this presumably is a dopamine autoreceptor effect, also independent of dopamine neuron firing (Costall et al. 1980; Creese et al. 1982; Strombom and Leidman 1982; Kuczenski et al. 1990; Furmidge et al. 1991; Mogenson and Wu 1991) . Thus, because we observed that locomotion is stimulated by LPO activation under dopamine receptor blockade and is not stimulated by amph-increased Acb extracellular dopamine if LPO activation is blocked, we conclude that the LPO mediates the locomotor response to increased Acb dopamine, but can activate locomotion, however tentatively, in the absence of dopamine signaling.
Behavior invigorated by LPO stimulation is coherent, integrated and purposeful in appearance. This highly coordinated character of LPO-elicited behavior is surprising because it is counterintuitive that it should be so. Amplification by bic of output transmitted from the LPO to brainstem motor effectors should also render disorganized any functionally important patterning of the impulses. Thus, that the physical structure of locomotion is not disrupted by LPO bic infusions suggests that it is the density of neural activity conducted from the LPO to the brainstem, not its pattern, that matters in LPO modulation of locomotion, consistent with longstanding doctrine holding behavioral pattern to be autonomously controlled by brainstem subject to modulation by descending signals mainly as pertains to initiation, cessation and gain (Ferrier 1876 (Ferrier /1966 Hinsey et al. 1930; Bard and Rioch 1937; Bard and Macht 1958; Woods 1964) .
VP control of behavior
In contrast to the accelerated, but, otherwise, putatively 'normal' locomotor behavior seen after LPO bic, a collection of distinctly aberrant, unnatural, presumably maladaptive movements, such as pivoting, backing, compulsive gnawing and ingesting while sated, was observed after VP infusions of bic. It is as if the VP can initiate and may provide at least part of the coding for a repertoire of actions, perhaps including turning, gnawing and ingesting, that, in the presence of the disruptive amplification associated with bilateral VP bic infusions, becomes the distorted caricatures of normal movements described here. VP projects to subthalamic and upper brainstem sites also innervated by the LPO (Haber et al. 1985 (Haber et al. , 1993 Groenwewgen et al. 1993 ) and, thus, like LPO, is neuroanatomically well positioned to modulate movement and locomotion. Like LPO, the VP also strongly innervates the VTA (Groenewegen et al. 1993 (Groenewegen et al. , 1994 . However, Floresco et al. (2003) observed no release of dopamine in the Acb upon VP stimulation, suggesting that the movements are not caused by VP-mediated stimulation of Acb-projecting VTA dopamine neurons. On the other hand, Koshikawa, Cools and colleagues were able to trigger bouts of vigorous pivoting and gnawing with unilateral infusion of dopamine agonists into the Acb shell (Koshikawa et al. 1996; Kitamura et al. 1999 Kitamura et al. , 2001 Ikeda et al. 2003 Ikeda et al. , 2007 , which they could block with VP musc infusions (Kitamura et al. 2001; Uchida et al. 2005) . While it thus seems unlikely that their effect models VP to VTA-stimulated Acb dopamine release, it nonetheless is difficult to conclude other than that dopamine signaling is in some way required. Consistent with their results, we have shown here that systemic dopamine D1 receptor blockade (but not D2 blockade) prevents the pivoting-gnawing response to bilateral stimulation of the VP. Where in the brain the necessary dopamine signaling occurs remains to be determined; perhaps in the VP itself (Napier and Maslowski-Cobuzzi 1994; Gong et al. 1999) . Considering all the data, it seems fair to speculate that pivots and gnawing are a distortion of a dopamine-dependent functional linkage between the Acb, VP and downstream somatomotor sites that differs fundamentally from locomotor activation associated with LPO stimulation, which also is modulated by dopamine signaling, but can proceed in its absence.
Disinhibition as a mechanism of action
Irrespective of differences in the motoric outcomes of LPO and VP activation, it defies prima facie logic that infusion of bic into either structure should increase movements, insofar as the outputs of LPO and VP are commonly thought to be GABAergic-activating them should suppress behavior. The pervasive notion that forebrain outputs are mainly GABAergic likely reflects the high reported percentages of GABAergic neurons in the VP (up to 90%) and LPO (50%) (Mugnaini and Oertel 1985; Ferraguti et al. 1990; Najlerahim et al. 1990 ) viewed in the light of earlier experiments showing that at least some descending forebrain efferents utilize GABA as a transmitter (e.g., Brownstein et al. 1977; Gonzales-Vegas and Pardey et al. 1979) . However, when markers of GABAergic phenotype were sought in targetspecified, i.e., retrogradely labeled, LPO and VP neurons, they were typically found to comprise only about 30% or less (Beckstead and Kersey 1985; Zahm et al. 1987; Schmued et al. 1989; Ray et al. 1992; Gritti et al. 1994; Veenman and Reiner 1994; Bell et al. 1995; Mascagni and McDonald 2009; Barker et al. 2017 ). This suggests a predominance of other transmitters, which, depending on the specific projection, might be excitatory amino acids (e.g., Geisler et al. 2007; Barker et al. 2017) or acetylcholine (Gritti et al. 1997) . However, phenotypic markers of utilization of GABA as a transmitter are notoriously difficult to detect, particularly in neurons that express GABA modestly (e.g., Ribak et al. 1978; Ferraguti et al. 1990; Ray et al. 1992) , so the actual numbers of GABAergic LPO and VP outputs may be more than reported. In any event, even small numbers of strategically localized GABAergic synapses can effectively curtail the activity of target neurons-particularly at dendritic branch points, by electrotonic 'amputation', and at the cell body and axon initial segment by 'strangulation' (Eccles 1964; Shepherd 1975, pg. 210) . Consequently, the observed tendency for increased movement to be linked to activation of the LPO or VP makes sense if LPO and VP GABAergic outputs act to inhibit a local inhibitory network, perhaps in the caudal brainstem, but possibly more widely distributed, that more directly controls the activity of brainstem motor effectors Mogenson et al. 1993) . Conversely, musc mediated inactivation of both the LPO and VP results in suppression of basal and amph-stimulated locomotion, which in turn makes sense only if inactivating LPO and VP permits said local inhibition to dominate. How excitatory outputs from the LPO and VP modulate locomotion, other than by activating the VTA (e.g., Reynolds et al. 2006 ), remains to be determined. They might, e.g., bypass the posited inhibitory network to act directly on principle neurons of brainstem somatomotor networks.
Differences in motoric effects elicited from the LPO and VP may reflect, at least in part, differences in how each interacts with aforementioned presumptive downstream inhibitory networks. Tangible manifestations of such interactions might include, e.g., differences we observed in the relative potencies of unilateral and bilateral infusions into the LPO and VP to elicit behavioral responses. That is, both unilateral and bilateral bic infusions into the LPO caused a motor response, whereas only bilateral VP bic infusions did so. Maximal locomotor responses generated by unilateral and bilateral LPO bic infusions were nearly identical, and the large mean response magnitude to bilateral LPO bic infusions only very modestly exceeded that seen after unilateral infusions. Whether this slight advantage reflects a particular mechanism requiring bilateral LPO activations or, alternatively, bilateral infusions simply double the likelihood of hitting previously reported 'sweet spots' associated with unilateral LPO stimulation of especially invigorated locomotion (Zahm et al. 2014 ) is unclear. Either way, the difference is sufficiently small that parsimony favors a simpler conclusion: the mean response magnitudes of both unilateral and bilateral LPO bic infusions are large and nearly equivalent. Likewise, similar reductions in both basal and amph-stimulated locomotion are produced by unilateral and bilateral infusions of musc into the LPO. Thus, infusions of bic or musc into one or both sides of the LPO exert nearly, if not precisely, the same level of control over locomotor invigoration. This fits well with the concept of autonomous execution of spontaneous locomotion by a dedicated brainstem-spinal somatomotor network controlled by a proximal inhibitory network. LPO input, whether from one or the other side of the midline or both, may initiate disinhibitory signaling that propagates throughout the entire inhibitory network, enabling LPO output frequency to command the vigor of locomotion.
In contrast, only bilateral infusions of bic into the VP elicited the aberrant pivoting, backing, gnawing and ingesting characteristic of VP bic infusions and only bilateral VP musc infusions produced maximal suppression of basal and amph-stimulated locomotion. Despite resulting from bilateral VP bic infusions, pivoting in one direction or the other typically predominated, but it was almost always accompanied by fewer pivots in the opposite direction and, occasionally, an about even split between the two directions was observed. While we observed no frankly asymmetrical locomotor responses after unilateral VP bic infusions, others have reported wide turning after unilateral VP infusions of opioids (Hoffman et al. 1991; Napier 1992; Napier et al. 1992 ) and musc (Kitamura et al. 2001) . However, the latter, due to their reported large diameter (> 30 cm) and relatively low frequency (about 4 turns/5 min max), may have been disrupted by or otherwise gone undetected in our square, 43 cm × 43 cm test space.
Another indication that LPO and VP outputs may have different interactions with presumptive downstream somatomotor inhibitory networks is the much greater suppression of behavior by musc infusion into the VP (when given bilaterally) as compared to LPO (when given unilaterally or bilaterally). That is, the moderate reduction in amph-stimulated locomotion produced by musc inactivation of LPO was outstripped by the near complete cessation of amph-stimulated locomotion and other movements following bilateral VP musc infusions. Thus, modulation of the gain of locomotion by the LPO may proceed under tight regulation by a stronger, permissive, tonically active (Mogenson et al. 1993 ) VP suppression of the presumptive tonic local inhibition.
This leaves remaining only to attach (even hypothetical) functional significance to the peculiar requirement that the VP be activated or inhibited bilaterally in order to produce the behavioral responses we have observed. Perhaps this goes to the need to select and inhibit competing motor programs to achieve smoothly integrated motor behavior (e.g., Mink 1996) . Distinct functional competencies of the LPO and VP likely compete for access to the same pool of brainstem-spinal premotor and motor neurons. That unilateral stimulation of the LPO is sufficient to trigger a maximal 'exploratory' behavioral response, suggests the somatomotor network is powerfully and bilaterally controlled even by unilateral LPO signaling. This is underscored by our earlier observation that infusion of bic into LPO on one side of the midline paired with a bic infusion into the VP on the other always results in an LPO-style locomotor activation (Zahm et al. 2014) . Nonetheless, bilateral inhibition of the VP profoundly suppresses both basal and amph-stimulated exploratory locomotion, suggesting that bilateral activation of the VP is necessary (and unilateral activation insufficient) to supplant LPO possession of the downstream somatomotor network and instead impress said network into service on behalf of discrete, faux-adaptive VP-elicited movements. While highly speculative, it seems possible that such an 'override' feature permits exploratory locomotion to be superseded by VP-elicited movements. In the absence of exogenously imposed stimulation and inhibition of the LPO and VP structures, as was done in this study, reported differences in their baselline firing frequencies (Mogenson et al. 1993) are consistent with mechanisms hypothesized here. However, further details of neuroanatomical organization and mechanisms to support such interactions remain to be worked out.
Functional considerations
Locomotor activation elicited by LPO stimulation and blocked by LPO inhibition simulates the acquisitive forward progression sometimes called 'exploratory' locomotion, which, in the behaving animal, can proceed independently of salient stimuli or be hastened by the promise of consummation, either remembered or cued by contextual environmental stimuli (Mary Christopher and Butter 1968; Hotsenpiller et al. 2001) . Consistent with responses to mnemonic and environmental cues, LPO receives major telencephalic input from the lateral septum and Acb shell (Zahm et al. 2013) , which themselves are dominated by massive inputs from the hippocampus and periamygdaloid, infralimbic, ventral prelimbic and ventral agranular insular cortex (Kelley and Domesick 1982; Room et al. 1985; McGeorge and Faull 1989; Groenewegen et al. 1990 Groenewegen et al. , 1987 Hurley et al. 1991; Berendse et al. 1992; Brog et al. 1993; Vertes 2004; Reynolds and Zahm 2005; Reichard et al. 2017 ) concerned with contextual, relatively undifferentiated aspects of behavioral synthesis (Heidbreder and Groenewegen 2003; Bannerman et al. 2004; McHugh et al. 2004; O'Mara et al. 2009; Cooper et al. 2006; Ito and Lee 2016) . Alternatively, stimulation of the VP simulates discrete movements, which, in proper context and undistorted, could be adaptive responses to salient, discrete stimuli. Accordingly, the VP gets quite strong input, via relays mainly in the Acb (Zahm and Brog 1992; Zahm 1999) , from the dorsal prelimbic, dorsal agranular insular and cingulate cortex (Room et al. 1985; McGeorge and Faull 1989; Groenewegen et al. 1990; Berendse et al. 1992; Brog et al. 1993; Vertes 2004; Reynolds and Zahm 2005) to which have been attributed more so the planning and execution of discrete, stimulus-driven adaptive behavioral responses (Kelley et al. 1997; Balleine and Dickinson 1998; Kelley 1999; Heidbreder and Groenewegen 2003; Vertes 2004 ). Thus, although driven absent of meaningful descending input, the respective actions elicited by LPO and VP bic infusions do not differ fundamentally from what in life each structure is called upon to execute by the cortical structures to which it is connected. The distinct functional competencies of the LPO and VP thus may have evolved and developed in close relation to those of the respective cortices to which each is connected.
Clinical note
Mechanisms that underlie the conversion of motivation to movement, while essential to normal adaptive behavior, assume clinical importance when considering addiction, i.e., 'compulsive repetition of actions known to be self-injurious'. Abstinence during addiction succumbs, as much as to its own persistent aversiveness, to the impossibly constant effort necessary to its maintenance, which must be exerted without expectation of immediate beneficial consequence. Even ardent motivation to abstain is readily annulled by actions directed toward gratification during even brief lapses in the continuous attention abstention demands. A better understanding of mechanisms that distinguish automatic from intentional actions, even at the fundamental level considered herein, could lead ultimately to strategies that retard recourse to repetition of self-destructive actions that are the sine qua non of relapse in addiction.
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